B9A-15062-88162
1 vaccination
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 802 / CO
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
-
2021-04-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-19
Survey response — 6 months, dose 1MedDRA: Hyperemesis gravidarum, Nasopharyngitis, Pregnancy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Got vaccinated right before i found out i was pregnant. Have hypermesis gravadarium and have been catching colds as well.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Pfizer-BioNTech |
Free text
Release 10 — 6 months, dose 1
Symptoms: Got vaccinated right before i found out i was pregnant. Have hypermesis gravadarium and have been catching colds as well.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hyperemesis gravidarum | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release